This week, a bankruptcy judge approved million-dollar bonuses for five executives at Stamford-based Purdue Pharma, a company at the center of the nation’s opioid epidemic.
CEO Craig Landau and four other executives will get a total of about $7 million through the bonuses. That comes after a judge approved millions for company-wide bonuses earlier this year.
The company has been in bankruptcy court since 2019. It settled with the U.S. Justice Department for more than $8 billion last year over its promotion of the painkiller Oxycontin.
Attorney General William Tong said in a statement that Purdue’s leadership continues to make decisions that do not confront and end the opioid epidemic.
